IP Verse

Medy Tox competitive analysis

Loading summary...

Latest patents of Medy Tox opposed by its competitors

Explore Medy Tox's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2692350
Jun 28, 2023Lyophilized Preparation Of Botulinum Toxin1
EP3079714
Nov 25, 2020Long Lasting Effect Of New Botulinum Toxin Formulations1

Latest publications and patents of Medy Tox New

Explore the latest publications and patents granted to Medy Tox, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Medy Tox

EP2692350
Jun 28, 2023Lyophilized Preparation Of Botulinum ToxinPatent Maintained As Amended
EP3079714
Nov 25, 2020Long Lasting Effect Of New Botulinum Toxin FormulationsRevoked

Latest PTAB cases involving Medy Tox

Discover the latest PTAB cases involving Medy Tox, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 24, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Medy Tox

IPR2021-01203Jul 1, 2021REVANCE THERAPEUTICSMEDY TOXInstitution Denied
IPR2021-01204Jul 1, 2021REVANCE THERAPEUTICSMEDY TOXInstitution Denied
PGR2019-00062Sep 4, 2019GALDERMAMEDY TOXFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Medy Tox with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MEDY TOX - 2 - 3
GALDERMA - - 4 -
IPSEN PHARMA33 - -
REVANCE THERAPEUTICS - 32 -